Mary J. Grendell
General Counsel at PROTARA THERAPEUTICS, INC.
Profile
Mary J.
Grendell is currently working as Secretary & General Counsel at Protara Therapeutics, Inc. She previously worked as Senior Counsel-Transactions Group at Amgen, Inc., Senior Counsel- Global Business Development at Mylan, Inc., and Secretary, Vice President & Deputy General Counsel at Intercept Pharmaceuticals, Inc. Ms. Grendell completed her undergraduate degree at Yale University and her graduate degree at The University of Pennsylvania Law School.
Mary J. Grendell active positions
| Companies | Position | Start |
|---|---|---|
| PROTARA THERAPEUTICS, INC. | General Counsel | - |
Former positions of Mary J. Grendell
| Companies | Position | End |
|---|---|---|
Mylan, Inc.
 Mylan, Inc. Pharmaceuticals: MajorHealth Technology Mylan, Inc. develops, manufactures, and licenses generic pharmaceuticals. The firm operates its business through two segments: Generics and Specialty. The Generics segment primarily develops, manufactures, sells and distributes generic or branded generic pharmaceutical products in tablet, capsule, injectable or transdermal patch form, as well as API. The Specialty segment engages mainly in the development, manufacture and sale of branded specialty nebulized and injectable products. The company was founded by Milan Puskar and Don Panoz in 1961 and is headquartered in Canonsburg, PA. | Corporate Officer/Principal | - |
| AMGEN INC. | Corporate Officer/Principal | - |
| INTERCEPT PHARMACEUTICALS, INC. | General Counsel | - |
Training of Mary J. Grendell
| Yale University | Undergraduate Degree |
| The University of Pennsylvania Law School | Graduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 3 |
|---|---|
| AMGEN INC. | Health Technology |
| INTERCEPT PHARMACEUTICALS, INC. | Health Technology |
| PROTARA THERAPEUTICS, INC. | Health Technology |
| Private companies | 1 |
|---|---|
Mylan, Inc.
Mylan, Inc. Pharmaceuticals: MajorHealth Technology Mylan, Inc. develops, manufactures, and licenses generic pharmaceuticals. The firm operates its business through two segments: Generics and Specialty. The Generics segment primarily develops, manufactures, sells and distributes generic or branded generic pharmaceutical products in tablet, capsule, injectable or transdermal patch form, as well as API. The Specialty segment engages mainly in the development, manufacture and sale of branded specialty nebulized and injectable products. The company was founded by Milan Puskar and Don Panoz in 1961 and is headquartered in Canonsburg, PA. | Health Technology |
- Stock Market
- Insiders
- Mary J. Grendell